DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

Q1 2023 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
3/31/2023
Date filed
5/15/2023
Form type
13F-HR
Num holdings
106
Total value ($000)
$4,485,670
Net value change ($000)
-345,338 (-7.1%)
New positions
18
Sold out positions
12
Turnover %
20.2%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q4 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
CPRX 62,237 56.9%
VTRS 51,624 46.4%
Deciphera Pharmaceuticals, Inc. 42,124 109.4%
Intra-Cellular Therapies, Inc. 39,746 NEW
ACH 33,245 144.4%
LUNG 26,862 NEW
DCGO 26,460 NEW
BCRX 23,060 NEW
CNC 21,615 46.6%
VTYX 20,670 NEW
Top Reduces (Value $000, Stocks/ETFs)
SRPT -165,398 -100.0%
NUVL -73,767 -12.4%
PHR -44,214 -100.0%
AMLX -41,286 -41.5%
IVERIC bio, Inc. -36,720 -50.1%
ImmunoGen, Inc. -31,537 -100.0%
ANAB -22,666 -63.0%
PCVX -22,508 -67.1%
SPRY -22,378 -23.7%
DAWN -20,746 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 Flynn Management LLC 028-11827